drugset / Trial / NCT03007225
Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study aimed to to compare the conventional transarterial chemoembolization (cTACE) with chemoembolization using doxorubicin drug eluting beads (DEB-TACE) for the treatment of hepatocellular carcinoma regarding short term efficacy and safety in first 3 months after embolization
Timeline
- Start
- 2015-07
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxorubicin | Other / unclassified | 100 mg | — |
| Comparator | Doxorubicin | Other / unclassified | 150 mg | — |
| Comparator | Gentamicin | Small molecule | 80 mg | — |
| Comparator | Urografin | Unknown | 5 ml | — |